Skip to main content

Non-Hodgkin's Lymphoma News (Page 2)

Related terms: Cancer, Non-Hodgkin's Lymphoma, Histiocytic Lymphoma, Lymphoblastic Lymphoma, Lymphocytic Lymphoma, Lymphoma, Histiocytic, Lymphoma, Lymphoblastic, Lymphoma, Lymphocytic, Lymphoma, Non-Hodgkin's, Non-Hodgkin Lymphoma

FDA Approves Beleodaq (belinostat) for Peripheral T-Cell Lymphoma

July 3, 2014 – The U.S. Food and Drug Administration today approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma (PTCL), a rare and fast-growing type of...

FDA Approves Imbruvica (ibrutinib) for Mantle Cell Lymphoma

November 13, 2013 – The U.S. Food and Drug Administration today approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma (MCL), a rare and aggressive type of blood cancer. MCL is...

FDA Approves Revlimid (lenalidomide) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma

SUMMIT, N.J.--(BUSINESS WIRE)--Jun. 5, 2013-- Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental new drug application (sNDA) for R...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Lymphoma

Related drug support groups

methotrexate, Rituxan, rituximab